Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00508365 · ClinicalTrials.gov registry record · Phase 1
Evaluation of Potential for Orthostatic Hypotension in Elderly Hypertensives
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 62
- Enrollment target
NCT00508365 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 62 participants.
The verdict
NCT00508365, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 62 participants
- Enrollment target
Study Summary
This is a multi-center, double-blind, randomized, placebo-controlled, 2-session crossover study to evaluate the incidence of orthostatic hypotension in elderly hypertensive subjects following co-administration of carvedilol CR and lisinopril.
Interventions
- DRUG Placebo
- DRUG Lisinopril
- DRUG Carvedilol CR capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2007-09-25 |
| Est. Completion | 2008-06-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00508365
The ClinicalTrials.gov registry entry for NCT00508365 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00508365 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00508365 about?
NCT00508365 is a clinical study titled "Evaluation of Potential for Orthostatic Hypotension in Elderly Hypertensives". This is a multi-center, double-blind, randomized, placebo-controlled, 2-session crossover study to evaluate the incidence of orthostatic hypotension in elderly hypertensive subjects following co-administration of carvedilol CR and lisinopril.
What is the current status of trial NCT00508365?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 62 participants. The study started on 2007-09-25. Estimated completion is 2008-06-03.
What interventions are being tested in trial NCT00508365?
The interventions under investigation include: Placebo (DRUG), Lisinopril (DRUG), Carvedilol CR capsules (DRUG).
Who is sponsoring clinical trial NCT00508365?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.